Search clinical trials for: Zanamivir

Total 25 results

Assistance Publique - Hôpitaux de Paris
GlaxoSmithKline; Hoffmann-La Roche

Terminated

Evaluation of Efficacity and Safety of Oseltamivir and Zanamivir (BIVIR)

Gastric Influenza

France
GlaxoSmithKline

Completed

Relenza® Sentinel Site Monitoring Program in Japan (SSMP)

Influenza, Human
GlaxoSmithKline

Completed

Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis)

Influenza, Human
GlaxoSmithKline

Completed

A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection

Influenza, Human

Japan
GlaxoSmithKline

Withdrawn

A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Subjects

Healthy Subjects
GlaxoSmithKline

Completed

Safety of Inhaled Zanamivir in Pregnancy

Influenza, Human
GlaxoSmithKline

Completed

A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza (ZORO)

Influenza, Human

Australia, Taiwan, Korea, Republic of, United States, Belgium, Canada, Germany, South Africa, Spain, United Kingdom, New Zealand, Thailand, India, China, Brazil, Hong Kong, Slovakia, Russian Federation, Denmark, Mexico, Czechia, H... and more
GlaxoSmithKline

Completed

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital

Influenza, Human

United States, Spain, France, Australia, South Africa, United Kingdom, Thailand, Hong Kong, Canada, Russian Federation, Japan, Norway, Brazil
GlaxoSmithKline

Completed

A Study to Evaluate the Effect of Intravenous Zanamivir on Cardiac Conduction in Healthy Volunteers

Influenza, Human

United States
University of Oxford
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Long Term Influenza Prophylaxis With Inhaled Zanamivir or Oral Oseltamivir (SEA 004)

Influenza

Thailand
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health

Completed

Pharmacokinetic Study of Oseltamivir and Intravenous Zanamivir in Healthy Adults

Virus Diseases | Influenza

Thailand
University of Missouri-Columbia

Active, not recruiting

Role of Neuraminidase Activity on Endothelial Dysfunction in Type 2 Diabetes (NAED)

Diabetes Mellitus, Type 2

United States
GlaxoSmithKline

Completed

Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 Days (NAI113625)

Influenza A Virus, H1N1 Subtype

United States
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China

Influenza A Virus Infection | Influenza B Virus Infection

China
George Washington University
Naval Medical Research Center; Clinica de la Costa; Global Disease Research

Recruiting

Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE) (ZAP-DENGUE)

Dengue Fever

Colombia
GlaxoSmithKline

Recruiting

An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection

Arthralgia | Influenza, Human

Spain, United Kingdom, Poland, Netherlands
GlaxoSmithKline

Completed

Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults

Influenza, Human

China
University of Oxford

Recruiting

A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza (AD ASTRA)

Influenza | Influenza, Human

Thailand
Mount Sinai Hospital, Canada
GlaxoSmithKline

Completed

Zanamivir Versus Trivalent Split Virus Influenza Vaccine (Stop-Flu-2)

Influenza

Canada
Hospices Civils de Lyon

Terminated

Efficacy and Safety of Combination Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A Infection (Combina)

Influenza A Infection

France
Biota Scientific Management Pty Ltd
Department of Health and Human Services

Terminated

Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza (FROSTY)

Influenza

United States
Chinese University of Hong Kong
Food and Health Bureau, Hong Kong; Hospital Authority

Terminated

A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection

Influenza | Upper Respiratory Tract Infection

China, Hong Kong
Biota Scientific Management Pty Ltd
Department of Health and Human Services

Completed

Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza (Igloo)

Influenza

United States, Peru, Hungary, Canada, South Africa, Estonia, Australia, Belgium, Bulgaria, Colombia, France, Germany, Latvia, Mexico, New Zealand, United Kingdom
Fred Hutchinson Cancer Center

Completed

TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients

Influenza

United States
GlaxoSmithKline

Completed

Prophylactic Efficacy of Relenza Against Influenza A and B

Pneumonia | Pulmonary Disease, Chronic Obstructive | Asthma | Sinusitis | Influenza, Human | Bronchitis | Respiratory Disease | Bronchospasm | Otitis Maedia | Exacerbation of COPD

Search clinical trials for: Zanamivir

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations